Meridian Bioscience Inc

Visual Financials
Company Name: Meridian Bioscience Inc
Ticker Symbol: VIVO
CIK Number: 0000794172
WWW Address: http://www.meridianbioscience.com
CEO: Mr. Jack P. Kenny
No. of Employees: 440
Common Issue Type: CS
Business Description:Meridian Bioscience, Inc. is a life science & diagnostics company. It is engaged in manufacture, sale and distribution of diagnostic test kits and bulk antigens, antibodies, among others.

 
Industry Information: DRUGS - Diagnostic Support [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 11.66 Up 0.14 11.12 11.97 11.55 11.38 11.20 248181
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 497.0 42.6 0.00 0.56 0.50 20.4 4.5 19.84 - 10.77
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close11.23$
PE Ratio - LTM20.4
Market Capitalisation497.0mil
Latest Shares Outstanding42.6mil
Earnings pS (EPS)0.56$
Dividend pS (DPS)0.50¢
Dividend Yield4.5%
Dividend Payout Ratio1%
Revenue per Employee365,079$
Effective Tax Rate0.2%
Float27.9mil
Float as % of Shares Outstanding0.7%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.10%
Gross Profit Margin61.1%
EBITDA Margin18.6%
Pre-Tax Profit Margin0.0%
Assets Turnover85.2%
Return on Assets (ROA)9.5%
Return on Equity (ROE)13.8%
Return on Capital Invested (ROCI)11.0%
Current Ratio5.8
Leverage Ratio (Assets/Equity)1.4
Interest Cover21.0
Total Debt/Equity (Gearing Ratio)0.29
LT Debt/Total Capital20.0%
Working Capital pS2.69$
Cash pS0.92$
Book-Value pS4.26$
Tangible Book-Value pS2.29$
Cash Flow pS0.98$
Free Cash Flow pS0.88$
KEY FIGURES (LTM): Price info
Price/Book Ratio2.63
Price/Tangible Book Ratio0.00
Price/Cash Flow11.5
Price/Free Cash Flow12.7
P/E as % of Industry Group95.0%
P/E as % of Sector Segment43.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of PaymentCash Payment
Dividend Rate0.50
Current Dividend Yield4.5
5-Y Average Dividend Yield3.4
Payout Ratio1.0
5-Y Average Payout Ratio96.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----0.6272,5431,112,666
4 Weeks11.7510.7711.57-2.9325,7116,188,522
13 Weeks17.7110.7716.44-31.7356,80622,478,778
26 Weeks18.8210.7718.35-38.8310,84438,544,771
52 Weeks19.8410.7715.50-27.5261,42665,356,719
YTD17.7110.77--33.4321,74734,748,735
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
11.3211.3112.3215.5615.550.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.030.20.03
Income-0.090.0-0.12
Dividend-0.080.0-0.15
Capital Spending-0.05NA-0.07
R&D11.29NA7.46
Normalized Inc.1.00NA5.13
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %5.6-0.48.7
Earnings %15.56.524.4
EPS %15.44.323.1
EPS $0.060.010.15
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio45.70
Current Ratio5.8
Quick Ratio (Acid Test)3.8
Liquidity Ratio (Cash)4.94
Receivables Turnover7.0
Average Collection Period51
Working Capital/Equity65.5
Working Capital pS2.71
Cash-Flow pS0.81
Free Cash-Flow pS0.72
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.02
Financial Leverage Ratio (Assets/Equity)0.3
Debt Ratio20.0
Total Debt/Equity (Gearing Ratio)0.29
LT Debt/Equity0.26
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities89.5
Interest Cover21.0
Interest/Capital Invested0.87
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.90
Current P/E Ratio - LTM20.40
Enterprise Value (EV)/EBITDA9.01
Enterprise Value (EV)/Free Cash Flow18.71
Dividend Yield4.5
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM2.63
Price/Cash Flow Ratio11.5
Price/Free Cash Flow Ratio - LTM12.7
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM25.2
P/E Ratio (26 weeks ago) - LTM24.7
P/E Ratio (52 weeks ago) - LTM27.3
5-Y High P/E Ratio33.6
5-Y Low P/E Ratio16.8
5-Y Average P/E Ratio30.5
Current P/E Ratio as % of 5-Y Average P/E-30
P/E as % of Industry Group95.0
P/E as % of Sector Segment43.0
Current 12 Month Normalized P/E Ratio - LTM25.6
PER SHARE FIGURES
LT Debt pS1.61
Current Liabilities pS0.87
Tangible Book Value pS - LTM2.29
Book Value pS - LTM4.26
Capital Invested pS5.29
Cash pS - LTM0.92
Cash Flow pS - LTM0.98
Free Cash Flow pS - LTM0.88
Earnings pS (EPS)0.56
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin14.32
Free Cash Flow Margin 5YEAR AVG17.14
Net Profit Margin0.2
Net Profit Margin - 5YEAR AVRG.0.1
Equity Productivity1.22
Return on Equity (ROE)0.1
Return on Equity (ROE) - 5YEAR AVRG.0.2
Capital Invested Productivity0.95
Return on Capital Invested (ROCI)0.2
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.2
Assets Productivity0.90
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin61.1
Gross Profit Margin - 5YEAR AVRG.0.6
EBITDA Margin - LTM18.6
EBIT Margin - LTM14.9
Pre-Tax Profit Margin0.2
Pre-Tax Profit Margin - 5YEAR AVRG.0.2
Effective Tax Rate1.1
Effective Tax Rate - 5YEAR AVRG.2.1
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee365,079
Net Income per Employee40,768
Average Collection Period
Receivables Turnover7.0
Day's Inventory Turnover Ratio
Inventory Turnover2.0
Inventory/Sales19.7
Accounts Payble/Sales2.93
Assets/Revenue1.11
Net Working Capital Turnover1.86
Fixed Assets Turnover1.90
Total Assets Turnover0.9
Revenue per $ Cash3.57
Revenue per $ Plant7.12
Revenue per $ Common Equity1.22
Revenue per $ Capital Invested0.95
Selling, General & Adm/tive (SG&A) as % of Revenue32.3
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue7.9
R&D Expense as % of Revenue - 5YEAR AVRG.7.9

  


Your Recent History
NASDAQ
VIVO
Meridian B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.